Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Attacking Diseases On Multiple Fronts — Pharmaceutical Development Combined With Cannabis?
Tickers ABBV AMGN CANF NVS
Tags General Partner Content Biotech
From Benzinga
Overview Of Value Stocks In The Healthcare Sector
Tickers CO DYNT NVS OVID
Tags CO Benzinga OVID
From Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
Tickers AGLE ALPN BCYC BTAI
Tags NVS Market News KTRA
From Benzinga
3 Things About Pfizer That Smart Investors Know
Tickers ABBV AZN BMY GSK
Tags SNY Recent Press Releases GSK
From Motley Fool
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
Tickers BIIB BLUE GILD IBB
Tags NASDAQ:BLUE,NASDAQ:IBB,NYSEARCA:XBI,NASDAQ:MRNA,,NYSE:NVS,NASDAQ:GILD,NYSE:MRK,NASDAQ:BIIB,NYSE:PFE XBI PFE
From InvestorPlace
Novartis' Breast Cancer PI3K Drug, Scores FDA Approval For Ultra-Rare Indication
Tickers NVS
Tags NVS Market News FDA
From Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
Tickers BGNE BTAI CCCC CTXR
Tags SLS IOVA FDA
From Benzinga
Novartis Highlights Four-Year Efficacy, Safety Data On Kesimpta In Multiple Sclerosis
Tickers NVS
Tags General Market News NVS
From Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
Tickers ACAD ARGX ATRA BMY
Tags Benzinga Biotech ATRA
From Benzinga
7 Biotech Stocks to Buy With Key Catalysts for April
Tickers ABBV ALNY AMGN APTX
Tags BMY NVS TARS
From InvestorPlace
Morning Brief: Top Stories Dominating Financial Media on Monday, April 4
Tickers AAPL CRRFY FRCOY MMM
Tags SPY Penny Stocks Top Stories
From Benzinga
Novartis To Strengthen Pipeline, Boost Productivity With New Organizational Structure
Tickers NVS
Tags General Management Briefs
From Benzinga
3 CEOs to Invest In
Tickers ANTM AXSM AZN GH
Tags JAZZ GH IMCR
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
Tickers ABBV AKBA ALNY AMRX
Tags Benzinga Biotech REGN
From Benzinga
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
Tickers ACMR AMGN BABA BGNE
Tags Hot Stocks WB BIDU
From InvestorPlace
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Tickers ADMP AFIB AFMD AGRX
Tags Biotech PDSB SCYX
From Benzinga
Which Company Has the Biggest COVID Program? The Answer Isn't Moderna.
Tickers AZN GRFS GSK JNJ
Tags PFE GRFS NVAX
From Motley Fool
Novartis Receives Positive CHMP Opinion For Kymriah In Follicular Lymphoma, Jakavi In GvHD
Tickers NVS
Tags Health Care Benzinga Biotech
From Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Tickers INCY NVO NVS
Tags Market News NVS Recent Press Releases
From Motley Fool
This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants
Tickers AMGN CANF NVS
Tags Benzinga Can/Fite BioPharma Ltd/ Biotech
From Benzinga
FDA Approves Novartis' Pluvicto As First Targeted Radioligand Therapy For Prostate Cancer
Tickers NVS
Tags Market News NVS General
From Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
Tickers AHPA APLS ASND ATHA
Tags LGND PFE CODX
From Benzinga
This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers
Tickers FUSN LNTH NVS PNT
Tags PSTV PNT Plus Therapeutics
From Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
Tickers ADMP AGTC ANAB APTO
Tags Offerings ORPH ADMP
From Benzinga
Morning Brief: Top Stories Dominating Financial Media on Tuesday, March 22
Tickers BABA BYDDY CP FB
Tags News Cryptocurrency TSLA
From Benzinga
Novartis Suspends Some Investment, Business Activities In Russia
Tickers NVS
Tags Benzinga Health Care Biotech
From Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
Tickers AAPL AMC AZN BABA
Tags XX:SXXP NVS GSK
From MarketWatch
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
Tickers NVS PFE VYGR
Tags NVS Recent Press Releases Market News
From Motley Fool
2 Top Stocks to Buy in March and Hold Forever
Tickers NVS RHHBY VIVO
Tags NVS Recent Press Releases Market News
From Motley Fool
Novartis's Data Reinforces Age-Appropriate Development With Zolgensma Gene Therapy Study
Tickers NVS
Tags Health Care Trading Ideas Large Cap
From Benzinga
< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.